AI brief of an SEC Form 8-K · KPET Ultra Paceline Corp (KPET)

KPET Ultra Paceline closes IPO over-allotment; $230 million placed in trust

Neutral Impact 3 of 5 financing Written later

KPET Ultra Paceline Corporation said the underwriter exercised its over-allotment option in full and bought 3,000,000 additional units on April 20, 2026, at $10.00 per unit, for $30,000,000 in gross proceeds. A total of $230,000,000 from the IPO, private placement and over-allotment was placed in a trust account, and an unaudited balance sheet as of April 20, 2026 reflecting these proceeds was filed as Exhibit 99.1. The filing covers financing and balance sheet effects only and does not report operating results.

Key points

  • Underwriter bought 3,000,000 over-allotment units on April 20, 2026, at $10.00 per unit, generating $30,000,000 in gross proceeds.
  • $230,000,000 placed in a trust account with Continental Stock Transfer & Trust Company, including $12,650,000 of deferred underwriting discounts and commissions.
  • Private placement of 235,000 units at $10.00 per unit to KPET Ultra Paceline Unit Holdings, LLC, generating $2,350,000 in gross proceeds.
  • Unaudited pro forma balance sheet as of April 20, 2026 filed as Exhibit 99.1; signed by Roger Edward Tamraz, President and Chief Financial Officer.

The filing

CompanyKPET Ultra Paceline Corp (KPET)
Form8-K, current report
Filed with the SECApr 22, 2026, 5:23 PM ET
Accession number0001213900-26-046698

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 22, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.